Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ford, Andria L
CRIZ, NCT05334576: Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA	Recruiting	N/A	31	US	Crizanlizumab	Andria Ford, Novartis Pharmaceuticals	Sickle Cell Disease	07/24	07/25